Newsletter | September 10, 2025

09.10.25 -- Why More Biotechs Are Starting Trials In Australia

SPONSOR

Webinar: Avoid the Wrecking Ball: Targeted Solutions for Struggling Trials

When a trial starts slipping off track, the instinct is often to “rescue” it — swap vendors, replace sites, or overhaul teams. But these costly moves usually treat symptoms, not the cause. The real problems often run deeper: misaligned protocols, overburdened sites, and unclear operational ownership. Discover how to fix what’s broken without hitting reset, so you stay on track, protect budgets, and deliver for patients.

DECENTRALIZED TRIALS

Closing The Gender Gap In Clinical Trials With Digital Devices

For decades, women have been underrepresented in clinical trials — a gap that’s not just unfortunate but dangerous. Digital devices might be the difference maker, says research physician Anita Phung, MRGCP, MRCP, MBBS, BSc (Hons).

Move The Needle On Clinical Research

Adaptable to any trial study, this team of experienced Certified Mobile Research Nurses travels directly to your trial participants, wherever they may be — at home, work, school, care centers, and more.

SPONSOR

Join industry leaders at the IRT conference in Boston, October 14-15, 2025, at The Westin Copley Place. This key event brings together the clinical supply community to explore cutting-edge technology updates, optimized data collection strategies, and innovative solutions for randomization and trial supply management. Network with experts and discover operational strategies to streamline clinical research and trial data management. Use VIP code IRT25LSC for 10% off when registering.

TRIAL MANAGEMENT

Why More Biotechs Are Starting Trials In Australia

Why are so many U.S. biotechs heading to Australia for their first-in-human trials? Speed, cost, and simplicity. In our latest piece, Megan Robertson and Tina Soulis break down how sponsors can move from protocol to first patient in just a few months—while saving money and generating data regulators will accept worldwide.

The Role Of FDA Initiatives In Early-Phase Oncology Trials

Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

Designing More Representative Trials Through Strategic Planning

Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.

Why EHR Data Is The Game Changer For Life Sciences Success

The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data is now essential for driving efficiency, innovation, and competitive advantage.

Breaking Through Barriers With Integrated Trial Optimization

In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.

Advice For Building Clinical Trial Model That Bridge The Digital Divide

Explore the strategic use of user-friendly digital systems to enhance participant engagement and reduce errors, thereby prioritizing a culture of quality over error tolerance.

Central IRB Services

With BRANY Central IRB Services you’ll get: competitive pricing, collaborative teamwork, solution flexibility, expert committee and IRB staff.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: